Vitamin D for Critically Traumatic Patients
Effects of High Doses of Liquid Vitamin D Supplementation on Clinical Outcomes in Critically Traumatic Patients.
National Taiwan University Hospital
100 participants
May 1, 2018
INTERVENTIONAL
Conditions
Summary
Trauma has been an important global public health issue. Yet it is the sixth cause of death in Taiwan, trauma brings great negative impact to national productivity since it presents specifically as the leading cause of death for the population aged below 40 years. According to the national databank from Formosa Association for the Surgery of Trauma, mortality rate in critically traumatic patients with injury severity score (ISS) ≥ 25 is as high as 23%. Vitamin D, a pleiotropic hormone, regulates directly functions of most organs and immune system. It has been proven that vitamin D insufficiency or deficiency would deteriorate survival of critically ill patients, while supplementation of high-dose vitamin D ameliorates the clinical outcomes. This study investigates whether multiple high doses of vitamin D supplementation in one week can decrease the mortality and morbidity in critically traumatic patients. The serum levels of calcidiol and PTH will be measured on Day 0, Day 3, Day 10, Day 15, Day 30 and Day 60 before and after vitamin D supplementation.
Eligibility
Inclusion Criteria1
- Major trauma adult (> 20 years old) with Injury Severity Score equal or higher than 9, who is admitted to ICU
Exclusion Criteria6
- Patients with the following conditions:
- Chronic liver disease
- Contraindication to enteral feeds
- Hypercalcemia
- Current use of vitamin D, estrogen, or medications for bone disease
- High risk of hypercalcemia, ex. metastatic cancer, primary hyperparathyroidism, sarcoidosis, multiple myeloma
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
High dose of vitamin D with 576,000 IU on the 3rd post-trauma day and 432,000 IU on the 10th post-trauma day (1,008,000 IU in total) is given orally or enterally via a feeding tube
Medium-chain triglyceride (MCT)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05449522